Praetor Pharmaceuticals Private Limited
About Praetor Pharmaceuticals Private Limited
Data last updated:
Praetor Pharmaceuticals Private Limited is a private limited company based in Bairi Gaon, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85110UP2019PTC112259. Its GSTIN is 09AAKCP3008J1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amit Kumar and Pranjal Pankaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bairi Gaon, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.65 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹11.04 Lakh (net margin 6.7%) and EBITDA of ₹15.59 Lakh (EBITDA margin 9.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 27% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Praetor Pharmaceuticals Private Limited's registered office is in Bairi Gaon, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No – 5 Arazi No – 923, Mahaveer Puram, Bairi Gaon, Uttar Pradesh, India – 208017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Praetor Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Praetor Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Praetor Pharmaceuticals Private Limited, buy the company report.
Financials of Praetor Pharmaceuticals Private Limited
FY 2025 filings availablePraetor Pharmaceuticals Private Limited reported revenue of ₹1.65 Cr (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 18% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | ||||
| Net Profit Margin | 6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Praetor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Praetor Pharmaceuticals Private Limited
Praetor Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Kumar | Director | 11 Jan 2019 | 7 Years 9 Months | Current |
| Pranjal Pankaj | Director | 30 Nov 2023 | 2 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Praetor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Praetor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Praetor Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCP3008J1ZA | Uttar Pradesh | Active | 11 Jan 2019 |
To see the full GST registrations and return filing status of Praetor Pharmaceuticals Private Limited, buy the company report.
Recent activity
Praetor Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Medha Das ceased to be Managing Director on 30 Nov 2023.
Frequently asked questions
Praetor Pharmaceuticals is an active private limited company based in Bairi Gaon, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 January 2019 (7+ years old) and is registered under CIN U85110UP2019PTC112259.
Praetor Pharmaceuticals has 2 current directors:
- Amit Kumar - Director
- Pranjal Pankaj - Director
The latest financial statements of Praetor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Praetor Pharmaceuticals is 09AAKCP3008J1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Praetor Pharmaceuticals is U85110UP2019PTC112259. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Praetor Pharmaceuticals was incorporated on 11 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Medha Das ceased to be Managing Director on 30 Nov 2023. Pranjal Pankaj was appointed as Director on 30 Nov 2023. Pranjal Pankaj ceased to be Managing Director on 28 Jan 2020. Praetor Pharmaceuticals has 4 board changes on record in total.
The registered office of Praetor Pharmaceuticals is at Plot No – 5 Arazi No – 923, Mahaveer Puram, Bairi Gaon, Uttar Pradesh, India – 208017.
Praetor Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Praetor Pharmaceuticals is compliant as of 14 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
